文献速递认知障碍与痴呆

V337M MAPT突变额颞叶痴呆的Tau-PET与病理相关性

Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations.
PubMed 文献 · Neurology · 2017-01-27

该研究评估[18F]AV1451 PET在V337M MAPT突变相关额颞叶痴呆患者中可视化tau病理的效能。结果显示先证者PET示踪剂滞留的分布与程度与母亲及无关V337M携带者的tau病理分布强关联,且与区域脑萎缩程度显著相关。结论支持[18F]AV1451可用于表征至少部分MAPT突变相关tau病理。

要点

  • V337M MAPT突变相关FTD中[18F]AV1451 PET可显示tau病理。
  • PET示踪剂滞留与尸检tau病理分布强关联。
  • PET结合与MRI脑萎缩程度显著相关。

核心结论

  • 研究支持[18F]AV1451可用于表征至少部分致病性MAPT突变相关的tau病理。

研究设计与样本

  • 病例研究,描述一名V337M MAPT突变相关FTD先证者的临床、结构MRI和[18F]AV1451 PET表现,并对比其患病母亲及一名无关V337M携带者的病理发现。

主要发现

  • 先证者[18F]AV1451滞留的拓扑分布与程度和其母亲及无关V337M携带者脑内tau病理分布强关联。
  • 先证者区域MRI脑萎缩程度与[18F]AV1451结合范围显著相关。
  • 先证者临床表现与结构MRI区域脑萎缩及[18F]AV1451 PET评估的tau累积程度强关联。

临床怎么用

  • 对于V337M等特定MAPT突变相关FTD,可考虑使用[18F]AV1451 PET辅助评估tau病理。

局限性

  • 原文未明确报告样本量、统计P值等定量指标,结论基于少数病例观察。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the efficacy of [18F]AV1451 PET in visualizing tau pathology in vivo in a patient with frontotemporal dementia (FTD) associated with the V337M microtubule-associated protein tau (MAPT) mutation. METHODS: MAPT mutations are associated with the deposition of hyperphosphorylated tau protein in neurons and glia. The PET tracer [18F]AV1451 binds with high affinity to paired helical filaments tau that comprises neurofibrillary tangles in Alzheimer disease (AD), while postmortem studies suggest lower or absent binding to the tau filaments of the majority of non-AD tauopathies. We describe clinical, structural MRI, and [18F]AV1451 PET findings in a V337M MAPT mutation carrier affected by FTD and pathologic findings in his affected mother and in an unrelated V337M MAPT carrier also affected with FTD. The biochemical similarity between paired helical filament tau in AD and MAPT V337M predicts that the tau pathology associated with this mutation constitutes a compelling target for [18F]AV1451 imaging. RESULTS: We found a strong association between topography and degree of [18F]AV1451 tracer retention in the proband and distribution of tau pathology in the brain of the proband's mother and the unrelated V337M mutation carrier. We also found a significant correlation between the degree of regional MRI brain atrophy and the extent of [18F]AV1451 binding in the proband and a strong association between the proband's clinical presentation and the extent of regional brain atrophy and tau accumulation as assessed by structural brain MRI and [18F]AV1451PET. CONCLUSION: Our study supports the usefulness of [18F]AV1451 to characterize tau pathology in at least a subset of pathogenic MAPT mutations.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Spina S, Schonhaut DR, Boeve BF, et al. Frontotemporal dementia with the V337M MAPT mutation: Tau-PET and pathology correlations. Neurology. 2017. PMID: 28130473. doi:10.1212/WNL.0000000000003636

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。